Autoimmune polyendocrinopathy - candidosis - ectodermal dystrophy (APECED) - A diagnostic and therapeutic challenge

Pediatric Endocrinology Reviews

Volumn 7, Issue 2, 2009, Pages 15-28

  Jaaskelainen J ^a   Perheentupa, J ^b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Adrenal failure; Autoimmune; Candidosis; Hepatitis; Hypoparathyroidism; Polyglandular; Prognosis

Indexed keywords

ALFACALCIDOL; AMPHOTERICIN B; AUTOANTIBODY; AUTOIMMUNE REGULATOR PROTEIN; CALCITRIOL; CALCIUM; CALCIUM ACETATE; CALCIUM CARBONATE; CHLORHEXIDINE; CITRATE CALCIUM; COLECALCIFEROL; DEXAMETHASONE; DIHYDROTACHYSTEROL; ECHINOCANDIN; ERGOCALCIFEROL; FLUCONAZOLE; FLUDROCORTISONE ACETATE; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; HYDROCORTISONE; INTERFERON ANTIBODY; INTERFERON OMEGA ANTIBODY; NATAMYCIN; NYSTATIN; PARATHYROID HORMONE[1-34]; POTASSIUM CHLORIDE; POTASSIUM SPARING DIURETIC AGENT; PREDNISOLONE; PREDNISONE; THIAZIDE DIURETIC AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADRENAL INSUFFICIENCY; ALOPECIA; ANTIBODY DETECTION; ANTIFUNGAL RESISTANCE; ASPLENIA; ATROPHIC GASTRITIS; AUTOIMMUNE HEPATITIS; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; AUTOIMMUNITY; CALCIUM BLOOD LEVEL; CATARACT; CONTINUOUS INFUSION; CORTICOSTEROID THERAPY; DIET SUPPLEMENTATION; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE COURSE; DRUG MEGADOSE; DRY EYE; ENAMEL HYPOPLASIA; EVENING DOSAGE; FEVER; FOLLOW UP; GENETIC SCREENING; GENITAL CANDIDIASIS; HORMONE SUBSTITUTION; HUMAN; HYPERCALCIURIA; HYPOALDOSTERONISM; HYPOCALCEMIA; HYPOGONADISM; HYPOPARATHYROIDISM; HYPOPITUITARISM; IMMUNOPATHOGENESIS; INFECTION RISK; INSULIN DEPENDENT DIABETES MELLITUS; INTERSTITIAL NEPHRITIS; INTESTINE INFECTION; IRIDOCYCLITIS; KERATITIS; LONG TERM CARE; LOSS OF FUNCTION MUTATION; LOW DRUG DOSE; MORNING DOSAGE; MOUTH HYGIENE; MUCOCUTANEOUS CANDIDIASIS; MULTIPLE CYCLE TREATMENT; MUTATIONAL ANALYSIS; MYOPATHY; NAIL DYSTROPHY; OPTIC NERVE ATROPHY; OSTEOPENIA; PERNICIOUS ANEMIA; PHENOTYPE; PROGNOSIS; RASH; RETINA DETACHMENT; REVIEW; SODIUM RESTRICTION; SQUAMOUS CELL CARCINOMA; THYROID DISEASE; VITILIGO;

ADRENAL INSUFFICIENCY; ADULT; AUTOANTIBODIES; BIOLOGICAL MARKERS; CANDIDIASIS, CHRONIC MUCOCUTANEOUS; CHILD; HUMANS; HYPOPARATHYROIDISM; INTERFERON TYPE I; MUTATION; POLYENDOCRINOPATHIES, AUTOIMMUNE; PROGNOSIS; SEVERITY OF ILLNESS INDEX; TRANSCRIPTION FACTORS;

EID: 78650021702     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (115)

1. Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, Heino M, Krohn KJ, Lalioti MD, Mullis PE, Antonarakis SE, Kawasaki K, Asakawa S, Ito F, Shimizu N. Positional cloning of the APECED gene. Nat Genet. 1997;17(4):393-398
2. Finnish-German APECED Consortium. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet. 1997;17(4):399-403
3. Eisenbarth GS, Gottlieb PA. Autoimmune polyendocrine syndromes. N Engl J Med 2004;350(20):2068-2079
4. Ahonen P, Myllarniemi S, Sipila I, Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 1990;322(26):1829-1836
5. Perheentupa J. APS-I/APECED: the clinical disease and therapy. Endocrinol Metab Clin North Am 2002;31(2):295-320
6. Perheentupa J. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab 2006;91(8):2843-2850
7. Zlotogora J, Shapiro MS. Polyglandular autoimmune syndrome type I among Iranian Jews. J Med Genet 1992;29(11):824-826
8. Rosatelli MC, Meloni A, Meloni A, Devoto M, Cao A, Scott HS, Peterson P, Heino M, Krohn KJ, Nagamine K, Kudoh J, Shimizu N, Antonarakis SE. A common mutation in Sardinian autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients. Hum Genet 1998;103(4):428-434 (Pubitemid 28542953)
9. Wolff AS, Erichsen MM, Meager A, Magitta NF, Myhre AG, Bollerslev J, Fougner KJ, Lima K, Knappskog PM, Husebye ES. Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene. J Clin Endocrinol Metab 2007;92(2):595-603
10. Dominguez M, Crushell E, Ilmarinen T, McGovern E, Collins S, Chang B, Fleming P, Irvine AD, Brosnahan D, Ulmanen I, Murphy N, Costigan C. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in the Irish population. J Pediatr Endocrinol Metab 2006;19(11):1343-1352 (Pubitemid 44963845)
11. Stolarski B, Pronicka E, Korniszewski L, Pollak A, Kostrzewa G, Rowinska E, Wlodarski P, Skorka A, Gremida M, Krajewski P, Ploski R. Molecular background of polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome in a Polish population: novel AIRE mutations and an estimate of disease prevalence. Clin Genet 2006;70(4):348-354 (Pubitemid 44323402)
12. Betterle C, Greggio NA, Volpato M. Clinical review 93: autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab 1998;83(4):1049-1055
13. Aaltonen J, Horelli-Kuitunen N, Fan JB, Bjorses P, Perheentupa J, Myers R, Palotie A, Peltonen L. High-resolution physical and transcriptional mapping of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy locus on chromosome 21q22.3 by FISH. Genome Res 1997;7(8):820-829
14. Bjorses P, Pelto-Huikko M, Kaukonen J, Aaltonen J, Peltonen L, Ulmanen I. Localization of the APECED protein in distinct nuclear structures. Hum Mol Genet 1999;8(2):259-266
15. Blechschmidt K, Schweiger M, Wertz K, Poulson R, Christensen HM, Rosenthal A, Lehrach H, Yaspo ML. The mouse aire gene: comparative genomic sequencing, gene organization, and expression. Genome Res 1999;9(2):158-166
16. Heino M, Peterson P, Kudoh J, Nagamine K, Lagerstedt A, Ovod V, Ranki A, Rantala I, Nieminen M, Tuukkanen J, Scott HS, Antonarakis SE, Shimizu N, Krohn K. Autoimmune regulator is expressed in the cells regulating immune tolerance in thymus medulla. Biochem Biophys Res Commun 1999;257(3):821-825 (Pubitemid 29301524)
17. Ruan QG, Wang CY, Shi JD, She JX. Expression and alternative splicing of the mouse autoimmune regulator gene (aire). J Autoimmun 1999;13(3):307-313
18. Zuklys S, Batciunaite G, Agarwal A, Fasler-Kan E, Palmer E, Hollander GA. Normal thymic architecture and negative selection are associated with aire expression, the gene defective in the autoimmune-polyendocrinopathy-candidiasis- ectodermal dystrophy (APECED). J Immunol 2000;165(4):1976-1983 (Pubitemid 30648747)
19. Derbinski J, Gabler J, Brors B, Tierling S, Jonnakuty S, Hergenhahn M, Peltonen L, Walter J, Kyewski B. Promiscuous gene expression in thymic epithelial cells is regulated at multiple levels. J Exp Med 2005;202(1):33-45
20. Kyewski B, Klein L. A central role for central tolerance. Annu Rev Immunol 2006;24:571-606
21. Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ, von Boehmer H, Bronson R, Dierich A, Benoist C, Mathis D. Projection of an immunological self shadow within the thymus by the aire protein. Science 2002;298(5597):1395-1401
22. Liston A, Lesage S, Wilson J, Peltonen L, Goodnow CC. Aire regulates negative selection of organ-specific T cells. Nat Immunol 2003;4(4):350-354 (Pubitemid 36432317)
23. Liston A, Gray DH, Lesage S, Fletcher AL, Wilson J, Webster KE, Scott HS, Boyd RL, Peltonen L, Goodnow CC. Gene dosage-limiting role of aire in thymic expression, clonal deletion, and organ-specific autoimmunity. J Exp Med 2004;200(8):1015-1026 (Pubitemid 39431126)
24. Anderson MS, Venanzi ES, Chen Z, Berzins SP, Benoist C, Mathis D. The cellular mechanism of aire control of T cell tolerance. Immunity 2005;23(2):227-239
25. Hassler S, Ramsey C, Karlsson MC, Larsson D, Herrmann B, Rozell B, Backheden M, Peltonen L, Kampe O, Winqvist O. Aire-deficient mice develop hematopoetic irregularities and marginal zone B-cell lymphoma. Blood 2006;108(6):1941-1948
26. Lindh E, Lind SM, Lindmark E, Hassler S, Perheentupa J, Peltonen L, Winqvist O, Karlsson MC. AIRE regulates T-cell-independent B-cell responses through BAFF. Proc Natl Acad Sci U S A 2008;105(47):18466-18471
27. Pontynen N, Strengell M, Sillanpaa N, Saharinen J, Ulmanen I, Julkunen I, Peltonen L. Critical immunological pathways are downregulated in APECED patient dendritic cells. J Mol Med 2008;86(10):1139-1152
28. Meloni A, Furcas M, Cetani F, Marcocci C, Falorni A, Perniola R, Pura M, Boe Wolff AS, Husebye ES, Lilic D, Ryan KR, Gennery AR, Cant AJ, Abinun M, Spickett GP, Arkwright PD, Denning D, Costigan C, Dominguez M, McConnell V, Willcox N, Meager A. Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 2008;93(11):4389-4397
29. Oftedal BE, Wolff AS, Bratland E, Kampe O, Perheentupa J, Myhre AG, Meager A, Purushothaman R, Ten S, Husebye ES. Radioimmunoassay for autoantibodies against interferon omega; its use in the diagnosis of autoimmune polyendocrine syndrome type I. Clin Immunol 2008;129(1):163-169
30. Meager A, Visvalingam K, Peterson P, Moll K, Murumagi A, Krohn K, Eskelin P, Perheentupa J, Husebye E, Kadota Y, Willcox N. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med 2006;3(7):e289
31. Levin M. Anti-interferon auto-antibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med 2006;3(7):e292
32. Zhang L, Barker JM, Babu S, Su M, Stenerson M, Cheng M, Shum A, Zamir E, Badolato R, Law A, Eisenbarth GS, Anderson MS. A robust immunoassay for anti-interferon autoantibodies that is highly specific for patients with autoimmune polyglandular syndrome type 1. Clin Immunol 2007;125(2):131-137 (Pubitemid 47566460)
33. Alimohammadi M, Bjorklund P, Hallgren A, Pontynen N, Szinnai G, Shikama N, Keller MP, Ekwall O, Kinkel SA, Husebye ES, Gustafsson J, Rorsman F, Peltonen L, Betterle C, Perheentupa J, Akerstrom G, Westin G, Scott HS, Hollander GA, Kampe O. Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. N Engl J Med 2008;358(10):1018-1028
34. Soderbergh A, Myhre AG, Ekwall O, Gebre-Medhin G, Hedstrand H, Landgren E, Miettinen A, Eskelin P, Halonen M, Tuomi T, Gustafsson J, Husebye ES, Perheentupa J, Gylling M, Manns MP, Rorsman F, Kampe O, Nilsson T. Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 2004;89(2):557-562
35. Ekwall O, Hedstrand H, Grimelius L, Haavik J, Perheentupa J, Gustafsson J, Husebye E, Kampe O, Rorsman F. Identification of tryptophan hydroxylase as an intestinal autoantigen. Lancet 1998;352(9124):279-283 (Pubitemid 28340146)
36. Ekwall O, Sjoberg K, Mirakian R, Rorsman F, Kampe O. Tryptophan hydroxylase autoantibodies and intestinal disease in autoimmune polyendocrine syndrome type 1. Lancet 1999;354(9178):568
37. Gebre-Medhin G, Husebye ES, Gustafsson J, Winqvist O, Goksoyr A, Rorsman F, Kampe O. Cytochrome P450IA2 and aromatic L-amino acid decarboxylase are hepatic autoantigens in autoimmune polyendocrine syndrome type I. FEBS Lett 1997;412(3):439-445 (Pubitemid 27337086)
38. Husebye ES, Gebre-Medhin G, Tuomi T, Perheentupa J, Landin-Olsson M, Gustafsson J, Rorsman F, Kampe O. Autoantibodies against aromatic L-amino acid decarboxylase in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 1997;82(1):147-150 (Pubitemid 27021286)
39. Hedstrand H, Ekwall O, Haavik J, Landgren E, Betterle C, Perheentupa J, Gustafsson J, Husebye E, Rorsman F, Kampe O. Identification of tyrosine hydroxylase as an autoantigen in autoimmune polyendocrine syndrome type I. Biochem Biophys Res Commun 2000;267(1):456-461 (Pubitemid 30072573)
40. Cervato S, Mariniello B, Lazzarotto F, Morlin L, Zanchetta R, Radetti G, De Luca F, Valenzise M, Giordano R, Rizzo D, Giordano C, Betterle C. Evaluation of the AIRE gene mutations in a cohort of Italian patients with autoimmune-polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) and in their relatives. Clin Endocrinol (Oxf) 2008
41. Podkrajsek KT, Bratanic N, Krzisnik C, Battelino T. Autoimmune regulator-1 messenger ribonucleic acid analysis in a novel intronic mutation and two additional novel AIRE gene mutations in a cohort of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients. J Clin Endocrinol Metab 2005;90(8):4930-4935
42. Halonen M, Eskelin P, Myhre AG, Perheentupa J, Husebye ES, Kampe O, Rorsman F, Peltonen L, Ulmanen I, Partanen J. AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy- candidiasis-ectodermal dystrophy phenotype. J Clin Endocrinol Metab 2002;87(6):2568-2574
43. Cihakova D, Trebusak K, Heino M, Fadeyev V, Tiulpakov A, Battelino T, Tar A, Halasz Z, Blumet P, Tawfik S, Krohn K, Lebl J, Peterson P. Novel AIRE mutations and P450 cytochrome autoantibodies in central and eastern european patients with APECED. Hum Mutat 2001;18(3):225-232 (Pubitemid 32807901)
44. Heino M, Peterson P, Kudoh J, Shimizu N, Antonarakis SE, Scott HS, Krohn K. APECED mutations in the autoimmune regulator (AIRE) gene. Hum Mutat 2001;18(3):205-211
45. Bjorses P, Halonen M, Palvimo JJ, Kolmer M, Aaltonen J, Eltonen P, Perheentupa J, Ulmanen I, Peltonen L. Mutations in the AIRE gene: effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protein. Am J Hum Genet 2000;66(2):378-392
46. Heino M, Scott HS, Chen Q, Peterson P, Maebpaa U, Papasawas MP, Mittaz L, Barras C, Rossier C, Chrousos GP, Stratakis CA, Nagamine K, Kudoh J, Shimizu N, Maclaren N, Antonarakis SE, Krohn K. Mutation analyses of North American APS-1 patients. Hum Mutat 1999;13(1):69-74
47. Pearce SH, Cheetham T, Imrie H, Vaidya B, Barnes ND, Bilous RW, Carr D, Meeran K, Shaw NJ, Smith CS, Toft AD, Williams G, Kendall-Taylor P. A common and recurrent 13-bp deletion in the autoimmune regulator gene in british kindreds with autoimmune polyendocrinopathy type 1. Am J Hum Genet 1998;63(6):1675-1684 (Pubitemid 30415730)
48. Kumar PG, Laloraya M, She JX. Population genetics and functions of the autoimmune regulator (AIRE). Endocrinol Metab Clin North Am 2002;31(2):321-338 (Pubitemid 34680180)
49. Cetani F, Barbesino G, Borsari S, Pardi E, Cianferotti L, Pinchera A, Marcocci C. A novel mutation of the autoimmune regulator gene in an Italian kindred with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, acting in a dominant fashion and strongly cosegregating with hypothyroid autoimmune thyroiditis. J Clin Endocrinol Metab 2001;86(10):4747-4752
50. Ilmarinen T, Eskelin P, Halonen M, Ruppell T, Kilpikari R, Torres GD, Kangas H, Ulmanen I. Functional analysis of SAND mutations in AIRE supports dominant inheritance of the G228W mutation. Hum Mutat 2005;26(4):322-331 (Pubitemid 41361800)
51. Collins SM, Dominguez M, Ilmarinen T, Costigan C, Irvine AD. Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis- ectodermal dystrophy syndrome. Br J Dermatol 2006;154(6):1088-1093
52. Ryan KR, Hong M, Arkwright PD, Gennery AR, Costigan C, Dominguez M, Denning D, McConnell V, Cant AJ, Abinun M, Spickett GP, Lilic D. Impaired dendritic cell maturation and cytokine production in patients with chronic mucocutanous candidiasis with or without APECED. Clin Exp Immunol 2008;154(3):406-414
53. Rautemaa R, Hietanen J, Niissalo S, Pinnen S, Perheentupa J. Oral and oesophageal squamous cell carcinoma - a complication or component of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED, APS-I). Oral Oncol 2007;43(6):607-613
54. Uittamo J, Siikala E, Kaihovaara P, Salaspuro M, Rautemaa R. Chronic candidosis and oral cancer in APECED-patients: Production of carcinogenic acetaldehyde from glucose and ethanol by Candida albicans. Int J Cancer 2009;124(3):754-756
55. Rautemaa R, Richardson M, Pfaller M, Koukita-Kahkota P, Perheentupa J, Saxen H. Decreased susceptibility of Candida albicans to azole antifungals: a complication of long-term treatment in autoimmune polyendocrinopathy- candidiasis-ectodermal dystrophy (APECED) patients. J Antimicrob Chemother 2007;60(4):889-892
56. Rautemaa R, Richardson M, Pfaller M, Perheentupa J, Saxen H. Reduction of fluconazole susceptibility of Candida albicans in APECED patients due to long-term use of ketoconazole and miconazole. Scand J Infect Dis 2008;40(11-12):904-907
57. Rautemaa R, Richardson M, Pfaller MA, Perheentupa J, Saxen H. Activity of amphotericin B, anidulafungin, caspofungin, micafungin, posaconazole, and voriconazole against Candida albicans with decreased susceptibility to fluconazole from APECED patients on long-term azole treatment of chronic mucocutaneous candidiasis. Diagn Microbiol Infect Dis 2008;62(2):182-185
58. Shoback D. Clinical practice. hypoparathyroidism. N Engl J Med 2008;359(4):391-403
59. Marx SJ. Hyperparathyroid and hypoparathyroid disorders. N Engl J Med 2000;343(25):1863-1875
60. Winer KK, Yanovski JA, Cutler GB, Jr. Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism. JAMA 1996;276(8):631-636
61. Winer KK, Yanovski JA, Sarani B, Cutler GB,Jr. A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism. J Clin Endocrinol Metab 1998;83(10):3480-3486 (Pubitemid 28500875)
62. Koch CA. Rapid increase in bone mineral density in a child with osteoporosis and autoimmune hypoparathyroidism treated with PTH 1-34. Exp Clin Endocrinol Diabetes 2001;109(6):350-354
63. Winer KK, Ko CW, Reynolds JC, Dowdy K, Keil M, Peterson D, Gerber LH, McGarvey C, Cutler GB,Jr. Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium. J Clin Endocrinol Metab 2003;88(9):4214-4220
64. Fong P, Goyal A, Brennan M, Park J, Moss L, Saltzman WM, Breuer CK. Development of PTH eluting microspheres for the treatment of hypoparathyroidism. J Surg Res 2007;143(2):195-199 (Pubitemid 350101554)
65. Winer KK, Sinaii N, Peterson D, Sainz B,Jr, Cutler GB,Jr. Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism. J Clin Endocrinol Metab 2008;93(9):3389-3395
66. Uibo R, Aavik E, Peterson P, Perheentupa J, Aranko S, Pelkonen R, Krohn KJ. Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison's disease. J Clin Endocrinol Metab 1994;78(2):323-328
67. Chen S, Sawicka J, Betterle C, Powell M, Prentice L, Volpato M, Rees Smith B, Furmaniak J. Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, addison's disease, and premature ovarian failure. J Clin Endocrinol Metab 1996;81(5):1871-1876
68. Ahonen P, Miettinen A, Perheentupa J. Adrenal and steroidal cell antibodies in patients with autoimmune polyglandular disease type I and risk of adrenocortical and ovarian failure. J Clin Endocrinol Metab 1987;64(3):494-500
69. Leisti S, Ahonen P, Perheentupa J. The diagnosis and staging of hypocortisolism in progressing autoimmune adrenalitis. Pediatr Res 1983;17(11):861-867 (Pubitemid 14231111)
70. Ronkainen MS, Harkonen T, Perheentupa J, Knip M. Characterization of the humoral immune response to glutamic acid decarboxylase in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) and/or type 1 diabetes. Eur J Endocrinol 2005;153(6):901-906
71. Tuomi T, Bjorses P, Falorni A, Partanen J, Perheentupa J, Lernmark A, Miettinen A. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 1996;81(4):1488-1494 (Pubitemid 26118581)
72. Gylling M, Tuomi T, Bjorses P, Kontiainen S, Partanen J, Christie MR, Knip M, Perheentupa J, Miettinen A. Ss-cell autoantibodies, human leukocyte antigen II alleles, and type 1 diabetes in autoimmune polyendocrinopathy- candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab 2000;85(12):4434-4440 (Pubitemid 32157614)
73. Perniola R, Falorni A, Clemente MG, Forini F, Accogli E, Lobreglio G. Organ-specific and non-organ-specific autoantibodies in children and young adults with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). Eur J Endocrinol 2000;143(4):497-503
74. Al-Herbish AS, Bailey JD, Kooh SW. Growth hormone deficiency in autoimmune polyglandular disease type 1. Saudi Med J 2000;21(8):765-768
75. Franzese A, Valerio G, Di Maio S, Iannucci MP, Bloise A, Tenore A. Growth hormone insufficiency in a girl with the autoimmune polyendocrinopathy- candidiasis-ectodermal dystrophy. J Endocrinol Invest 1999;22(1):66-69 (Pubitemid 29095017)
76. Faustini-Fustini M. Growth hormone deficiency in APECED. J Endocrinol Invest 1999;22(11):886
77. Cemeroglu AP, Bober E, Dundar B, Buyukgebiz A. Autoimmune polyglandular endocrinopathy and anterior hypophysitis in a 14 year-old girl presenting with delayed puberty. J Pediatr Endocrinol Metab 2001;14(7):909-914
78. Beressi N, Beressi JP, Cohen R, Modigliani E. Lymphocytic hypophysitis. A review of 145 cases. Ann Med Interne (Paris) 1999;150(4):327-341
79. Ward L, Paquette J, Seidman E, Huot C, Alvarez F, Crock P, Delvin E, Kampe O, Deal C. Severe autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy in an adolescent girl with a novel AIRE mutation: Response to immunosuppressive therapy. J Clin Endocrinol Metab 1999;84(3):844-852
80. Bensing S, Fetissov SO, Mulder J, Perheentupa J, Gustafsson J, Husebye ES, Oscarson M, Ekwall O, Crock PA, Hokfelt T, Hulting AL, Kampe O. Pituitary autoantibodies in autoimmune polyendocrine syndrome type 1. Proc Natl Acad Sci U S A 2007;104(3):949-954
81. Fetissov SO, Bensing S, Mulder J, Le Maitre E, Hulting AL, Harkany T, Ekwall O, Skoldberg F, Husebye ES, Perheentupa J, Rorsman F, Kampe O, Hokfelt T. Autoantibodies in autoimmune polyglandular syndrome type I patients react with major brain neurotransmitter systems. J Comp Neurol 2009;513(1):1-20
82. Smith D, Stringer MD, Wyatt J, O'Meara M, Davison S, Cheetham TD, McClean P. Orthotopic liver transplantation for acute liver failure secondary to autoimmune hepatitis in a child with autoimmune polyglandular syndrome type 1. Pediatr Transplant 2002;6(2):166-170
83. Michele TM, Fleckenstein J, Sgrignoli AR, Thuluvath PJ. Chronic active hepatitis in the type I polyglandular autoimmune syndrome. Postgrad Med J 1994;70(820):128-131 (Pubitemid 24074636)
84. Goldstein NS, Rosenthal P, Sinatra F, Dehner LP. Liver disease in polyglandular autoimmune disease type one: Clinicopathologic study of three patients and review of the literature. Pediatr Pathol Lab Med 1996;16(4):625-636 (Pubitemid 26268693)
85. Obermayer-Straub P, Perheentupa J, Braun S, Kayser A, Barut A, Loges S, Harms A, Dalekos, Strassburg CP, Manns MP. Hepatic autoantigens in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Gastroenterology 2001;121(3):668-677
86. Clemente MG, Obermayer-Straub P, Meloni A, Strassburg CP, Arangino V, Tukey RH, De Virgiliis S, Manns MP. Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab 1997;82(5):1353-1361
87. Burdmann EA, Andoh TF, Yu L, Bennett WM. Cyclosporine nephrotoxicity. Semin Nephrol 2003;23(5):465-476
88. Scire G, Magliocca FM, Cianfarani S, Scalamandre A, Petrozza V, Bonamico M. Autoimmune polyendocrine candidiasis syndrome with associated chronic diarrhea caused by intestinal infection and pancreas insufficiency. J Pediatr Gastroenterol Nutr 1991;13(2):224-227
89. Buchman AL, Rao SM. A patient with a polyglandular autoimmune syndrome involving the salivary glands, thyroid, intestine, and pancreas. Dig Dis Sci 2004;49(4):590-593
90. Bereket A, Lowenheim M, Blethen SL, Kane P, Wilson TA. Intestinal lymphangiectasia in a patient with autoimmune polyglandular disease type I and steatorrhea. J Clin Endocrinol Metab 1995;80(3):933-935
91. Makharia GK, Tandon N, Stephen Nde J, Gupta SD, Tandon RK. Primary intestinal lymphangiectasia as a component of autoimmune polyglandular syndrome type I: a report of 2 cases. Indian J Gastroenterol 2007;26(6):293-295 (Pubitemid 351629635)
92. Padeh S, Theodor R, Jonas A, Passwell JH. Severe malabsorption in autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy syndrome successfully treated with immunosuppression. Arch Dis Child 1997;76(6):532-534 (Pubitemid 27334725)
93. Gambineri E, Perroni L, Passerini L, Bianchi L, Doglioni C, Meschi F, Bonfanti R, Sznajer Y, Tommasini A, Lawitschka A, Junker A, Dunstheimer D, Heidemann PH, Cazzola G, Cipolli M, Friedrich W, Janic D, Azzi N, Richmond E, Vignola S, Barabino A, Chiumello G, Azzari C, Roncarolo MG, Bacchetta R. Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity. J Allergy Clin Immunol 2008;122(6):1105-1112
94. Tawfik S, Azim MA, Peterson P, Donaldson MD. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy presenting with severe keratopathy in an Egyptian patient with a homozygous R139X mutation. Horm Res 2005;64(2):96-99
95. Merenmies L, Tarkkanen A. Chronic bilateral keratitis in autoimmune polyendocrinopathy-candidiadis-ectodermal dystrophy (APECED). A long-term follow-up and visual prognosis. Acta Ophthalmol Scand 2000;78(5):532-535
96. Tarkkanen A, Merenmies L. Corneal pathology and outcome of keratoplasty in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). Acta Ophthalmol Scand 2001;79(2):204-207
97. Shah M, Holland E, Chan CC. Resolution of autoimmune polyglandular syndrome-associated keratopathy with keratolimbal stem cell transplantation: case report and historical literature review. Cornea 2007;26(5):632-635
98. Hedstrand H, Perheentupa J, Ekwall O, Gustafsson J, Michaelsson G, Husebye E, Rorsman F, Kampe O. Antibodies against hair follicles are associated with alopecia totalis in autoimmune polyendocrine syndrome type I. J Invest Dermatol 1999;113(6):1054-1058 (Pubitemid 30013352)
99. Myllarniemi S, Perheentupa J. Oral findings in the autoimmune polyendocrinopathy-candidosis syndrome (APECS) and other forms of hypoparathyroidism. Oral Surg Oral Med Oral Pathol 1978;45(5):721-729 (Pubitemid 8344425)
100. Perniola R, Tamborrino G, Marsigliante S, De Rinaldis C. Assessment of enamel hypoplasia in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). J Oral Pathol Med 1998;27(6):278-282
101. McGovern E, Fleming P, Costigan C, Dominguez M, Coleman DC, Nunn J. Oral health in autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED). Eur Arch Paediatr Dent 2008;9(4):236-244
102. Starzyk J, Kumorowicz-Kopiec M, Kowalczyk M, Starzyk B, Rybakowa M, Dziatkowiak H. Natural history of asplenism in APECED-patient report. J Pediatr Endocrinot Metab 2001;14(4):443-449
103. Ulinski T, Perrin L, Morris M, Houang M, Cabrol S, Grapin C, Chabbert-Buffet N, Bensman A, Deschenes G, Giurgea I. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome with renal failure: impact of posttransplant immunosuppression on disease activity. J Clin Endocrinol Metab 2006;91(1):192-195
104. Makitie O, Sochett EB, Bondestam S, Sipila I, Perheentupa J. Bone health in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED): findings in 25 adults. Clin Endocrinol (Oxf) 2006;64(5):489-494
105. Harris M, Kecha O, Deal C, Howlett CR, Deiss D, Tobias V, Simoneau-Roy J, Walker J. Reversible metaphyseal dysplasia, a novel bone phenotype, in two unrelated children with autoimmunepolyendocrinopathy-candidiasis-ectodermal dystrophy: clinical and molecular studies. J Clin Endocrinol Metab 2003;88(10):4576-4585
106. Podkrajsek KT, Milenkovic T, Odink RJ, Claasen-van der Grinten HL, Bratanic N, Hovnik T, Battelino T. Detection of a complete autoimmune regulator gene deletion and two additional novel mutations in a cohort of patients with atypical phenotypic variants of autoimmune polyglandular syndrome type 1. Eur J Endocrinol 2008;159(5):633-639
107. Alimohammadi M, Dubois N, Skoldberg F, Hallgren A, Tardivel I, Hedstrand H, Haavik J, Husebye ES, Gustafsson J, Rorsman F, Meloni A, Janson C, Vialettes B, Kajosaari M, Egner W, Sargur R, Ponten F, Amoura Z, Grimfeld A, De Luca F, Betterle C, Perheentupa J, Kampe O, Carel JC. Pulmonary autoimmunity as a feature of autoimmune polyendocrine syndrome type 1 and identification of KCNRG as a bronchial autoantigen. Proc Natl Acad Sci U S A 2009;106(11):4396-4401
108. Korniszewski L, Kurzyna M, Stolarski B, Torbicki A, Smerdel A, Ploski R. Fatal primary pulmonary hypertension in a 30-yr-old female with APECED syndrome. Eur Respir J 2003;22(4):709-711
109. Sato K, Nakajima K, Imamura H, Deguchi T, Horinouchi S, Yamazaki K, Yamada E, Kanaji Y, Takano K. A novel missense mutation of AIRE gene in a patient with autoimmune polyendocrinopathy, candidiasis and ectodermal dystrophy (APECED), accompanied with progressive muscular atrophy: case report and review of the literature in Japan. Endocr J 2002;49(6):625-633 (Pubitemid 36119582)
110. Valenzise M, Meloni A, Betterle C, Giometto B, Autunno M, Mazzeo A, Cao A, De Luca F. Chronic inflammatory demyelinating polyneuropathy as a possible novel component of autoimmune poly-endocrine-candidiasis-ectodermal dystrophy. Eur J Pediatr 2009;168(2):237-240
111. Capalbo D, Elefante A, Spagnuolo Ml, Mazza C, Betterle C, Pignata C, Salerno M. Posterior reversible encephalopathy syndrome in a child during an accelerated phase of a severe APECED phenotype due to an uncommon mutation of AIRE. Clin Endocrinol (Oxf) 2008;69(3):511-513
112. Rosa DD, Pasqualotto AC, Denning DW. Chronic mucocutaneous candidiasis and oesophageal cancer. Med Mycol 2008;46(1):85-91
113. De Luca F, Valenzise M, Alaggio R, Arrigo T, Crisafulli G, Salzano G, Cervato S, Mariniello B, Lazzarotto F, Betterle C. Sicilian family with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) and tethal lung disease in one of the affected brothers. Eur J Pediatr 2008; 167(11):1283-1288
114. N FM, Pura M, A SBW, Vanuga P, Meager A, P MK, Husebye ES. Autoimmune polyendocrine syndrome type I in Slovakia: relevance of screening patients with autoimmune Addison's disease. Eur J Endocrinol 2008;158(5):705-709
115. Porzionato A, Zancaner S, Betterle C, Ferrara SD. Fatal toxic epidermal necrolysis in autoimmune polyglandular syndrome type I. J Endocrinol Invest 2004;27(5):475-479 (Pubitemid 38961262)